Home / Market News / $ACB
benzinga Corporate Catalyst Impact 85/100 ● neutral

Aurora Cannabis' Board Recommends Shareholders Reject Offer By Curaleaf Holdings

Oct 14, 2026, 7:55 PM UTC · Primary ticker $ACB

Aurora Cannabis' Board of Directors, following a special committee's unanimous recommendation, is advising shareholders to reject Curaleaf's hostile takeover offer. This indicates a strong internal opposition to the acquisition, likely leading to continued negotiation or a withdrawal of the bid.

Aurora Cannabis' Board of Directors has unanimously recommended that shareholders reject the hostile takeover offer from Curaleaf Holdings. This is a significant development in the potential acquisition, signaling that Aurora's management believes the offer undervalues the company or is not in the best interest of its shareholders. For traders, this creates uncertainty around the deal's completion; short-term, ACB's stock might see volatility as the market reacts to the rejection, while CURA's stock could face downward pressure if the market perceives the deal as less likely to close. Long-term, if the bid is ultimately withdrawn, Aurora will remain an independent entity, and Curaleaf will need to reassess its growth strategy.

$ACB neutral Target of hostile bid, board recommends rejection
$CURA negative Hostile bid rejected by target's board
$CURLF negative Hostile bid rejected by target's board (OTCQX listing)
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.